Common Contracts
3 similar Underwriting Agreement contracts by Immunovaccine Inc., New Pacific Metals Corp
UNDERWRITING AGREEMENTUnderwriting Agreement • September 29th, 2023 • New Pacific Metals Corp • Gold and silver ores
The undersigned, Raymond James Ltd. (“Raymond James”) and Eight Capital (together with Raymond James, the “Co-Lead Underwriters”) and PI Financial Corp., Roth Canada, Inc., Cormark Securities Inc. and Echelon Wealth Partners Inc. (collectively with the with the Co-Lead Underwriters, the “Underwriters”) understand that New Pacific Metals Corp., a company organized under the laws of the Province of British Columbia (the “Company”), proposes to issue and sell an aggregate of 13,208,000 common shares of the Company (the “Firm Shares”) to the Underwriters. The Underwriters hereby offer to purchase from the Company all but not less than all of the Firm Shares on a “bought deal” basis, at the purchase price of $2.65 per share (the “Purchase Price”) for aggregate gross proceeds of C$35,001,200.
UNDERWRITING AGREEMENTUnderwriting Agreement • June 30th, 2022 • British Columbia
provisions of the articles or notice of articles of the Company or any applicable British Columbia corporate law or Applicable Securities Laws in the Province of British Columbia;
UNDERWRITING AGREEMENTUnderwriting Agreement • May 1st, 2018 • Immunovaccine Inc. • Ontario
The undersigned, Echelon Wealth Partners Inc. (“Echelon”), National Bank Financial Inc. (“National” and together with Echelon, the “Lead Underwriters”) and Mackie Research Capital Corporation (“Mackie” and together with the Lead Underwriters, the “Underwriters”), understand that Immunovaccine Inc. (the “Company”) proposes to issue and sell (the “Offering”) 7,692,308 common shares of the Company (each an “Offered Share”). The Underwriters, hereby severally, and not jointly, nor jointly and severally, offer to purchase from the Company all of the Offered Shares on a “bought deal” basis, at the purchase price of $1.30 per Offered Share (the “Offering Price”) for aggregate gross proceeds to the Company of $10,000,000. The Underwriters shall have the right to cause the Offered Shares to be purchased by the substituted purchasers in place of the Underwriters (“Substituted Purchasers”), and the obligation of the Underwriters to purchase the Offered Shares shall be reduced to an amount equal t
